reports
- Marc Hesselink
- CFA
- Thymen Rundberg
ASM International/Technology outperformance/BUY
AI strength and ongoing technology transitions are key tailwinds for ASM International (ASM). We expect the company to significantly outgrow its peers. While we leave our longer-term revenue estimates largely unchanged, we increase our operational leverage assumptions. We reiterate our BUY rating and raise our target price to €700 per share (from €650). ASM remains on the ING Benelux Favourites list.
- Hilde Van Boxstael
- Livio Luyten
- Thomas Couvreur
- Wim Hoste
- Wim Hoste
Corbion Strategy update shows increased focus, upgrade to BUY
Corbion's BRIGHT 2030 strategy update revealed an increasing focus on clean label Food Ingredients, Nutrition and Biomedical Polymers/Pharma. Biochemicals are being de-prioritized and the strategic ownership review on PLA will most likely result in an exit. Financial targets include a 3-6% annual organic sales growth target and a c 2pp increase in the adjusted EBITDA margin by 2028. A disciplined approach on capex is expected to result in an average 8% FCF yield in the coming years with a streng...
- Marc Hesselink
- CFA
- Thymen Rundberg
BE Semiconductor Industries/Order momentum building up/BUY
Beyond an eventual cyclical recovery, we remain highly positive on BESI's long-term hybrid bonding opportunity. We expect industry-wide adoption of chiplet architecture over the coming years, which should drive significant demand for hybrid bonding. BESI is well positioned to maintain its leadership in this space. We reiterate our Buy rating and slightly increase our target price to €155 per share.
- Roy Külter
- Steven Boumans
- Jeremy Garnier
- Jeremy Garnier
- Jacob Mekhael
- Kristof Samoy
- Thibault Leneeuw
Melexis: update on the share buy-back program
Melexis: update on the share buy-back program Press release - Regulated Information Ieper, Belgium – 24 November 2025, 17.45 hrs CET Further to the initiation of the share buy-back program announced on 10 December 2024, Melexis reports the purchase of 65,000 Melexis shares on Euronext Brussels in the period from 17 to 21 November 2025. Trade dateTotal shares purchasedAverage price (€)Min price (€)Max price (€)Buyback amount (€)17/11/202513,00054.7254.5055.60711,30218/11/202513,00053.2852.9553.75692,61019/11/202512,00053.2552.7053.40639,03020/11/202513,00051.3650.8554.10667,70321/11/2025...
Melexis: update over het aandeleninkoopprogramma
Melexis: update over het aandeleninkoopprogramma Persbericht - Gereglementeerde informatie Ieper, België – 24 november 2025, 17.45 uur CET Naar aanleiding van het aandeleninkoopprogramma dat op 10 december 2024 werd aangekondigd, maakt Melexis bekend dat er 65.000 eigen aandelen ingekocht werden op Euronext Brussel tussen 17 en 21 november 2025. InkoopdatumAantal verworven aandelenGemiddelde prijs (€)Laagste prijs (€)Hoogste prijs (€)Aankoop bedrag (€)17/11/202513.00054,7254,5055,60711.30218/11/202513.00053,2852,9553,75692.61019/11/202512.00053,2552,7053,40639.03020/11/202513.00051,3650...
Heineken N.V. reports the progress of transactions under its current s...
Heineken N.V. reports the progress of transactions under its current share buyback programme Heineken N.V. reports the progress of transactions under its current share buyback programme Amsterdam, 24 November 2025 - Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) hereby reports transaction details related to the first €750 million tranche of its €1.5 billion share buyback programme as communicated on 12 February 2025. From 17 November 2025 up to and including 21 November 2025 a total of 180,750 shares were repurchased on exchange at an average price of € 69.14. During the same period, 180,2...
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Mathijs Geerts Danau
- Thibault Leneeuw
- Wim Lewi
- Emira Sagaama
- Emmanuel Matot
- Emira Sagaama
- Emmanuel Matot
- ING Helpdesk
Benelux Morning Notes
Ackermans & van Haaren: 3Q TU mostly in line, better inflows, markets support AuMs. Ahold Delhaize: Peer Walmart 3Q25/26 results. Bekaert: Soft 3Q25 update, FY guidance further toned down. Corbion: Evolution, not revolution. Universal Music Group: Peer Warner Music 11% revenue and 8% OIBDA beat
- Hilde Van Boxstael
- Livio Luyten
- Wim Hoste
- Wim Lewi
- Wim Hoste
Corbion Feedback CMD
Below we list the key highlights from the CMD. We remind that Corbion announced new financial targets for 2026-2028 including a 3-6% organic sales growth target (KBCS 3.0%) and an 18% adjusted EBITDA margin target (KBCS 17%), vs a 16.3% margin YTD. The announced strategic review on PLA is no surprise and will most likely result in an exit of Corbion, while still remaining the lactic acid supplier to the buyer. Biochemicals will be de-emphasized, which will put the growth focus on food preservati...
- Robert Jan Vos
- ING Helpdesk
- Hilde Van Boxstael
- Livio Luyten
- Lynn Hautekeete
- Michiel Declercq
- Wim Hoste
- Wim Lewi
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.